Literature DB >> 19880214

Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.

Haiying Lin1, Zilin Lin, Chun Meng, Jingzhong Huang, Yanghao Guo.   

Abstract

The efforts were focused on exploring alternative pneumococcal vaccine strategies, aimed at addressing the shortcomings of existing formulations, without compromising efficacy. We generated a stable Escherichia coli construct expressing functional recombinant PsaA and prepared CPS-rPsaA conjugate. The distribution of anti-CPS antibody response was almost completely of IgG2a subclass followed by IgG3 and low level of IgG1 subclass, which was opposite to the distribution of anti-PsaA IgG subclass antibodies. Though rPsaA was not detectable on the surface of the pneumococcal strain, the CPS-rPsaA conjugate possessed more accessibility to the surface of the strain. Mice immunized with conjugate exhibited rapid bacterial clearance from blood for the first 23h and afterward provided the best protection against challenge with pneumococcal 23F strain. Copyright 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880214     DOI: 10.1016/j.imbio.2009.08.008

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  4 in total

1.  Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Giorgio Scarpellini; Ascencion Torres-Escobar; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

2.  An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.

Authors:  Shubhamoy Ghosh; Krishnendu Chakraborty; Theeya Nagaraja; Surajit Basak; Hemanta Koley; Shanta Dutta; Utpala Mitra; Santasabuj Das
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

3.  Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation.

Authors:  Aline Pillot; Alain Defontaine; Amina Fateh; Annie Lambert; Maruthi Prasanna; Mathieu Fanuel; Muriel Pipelier; Noemi Csaba; Typhaine Violo; Emilie Camberlein; Cyrille Grandjean
Journal:  Front Chem       Date:  2019-11-01       Impact factor: 5.221

4.  In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant.

Authors:  Zohreh Bahadori; Mona Shafaghi; Hamid Madanchi; Mohammad Mehdi Ranjbar; Ali Akbar Shabani; Seyed Fazlollah Mousavi
Journal:  J Transl Med       Date:  2022-09-04       Impact factor: 8.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.